trial · primary record
azenosertib
High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer
| Phase | Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 310 |
| Primary completion | 2027-06-30 |
| Primary endpoint | Objective Response Rate (ORR) defined by RECIST v1.1 [Part 2] |
| Registry ID | NCT05128825 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-30T14:45:35.563Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT05128825
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.